跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 107 条关于
“PAK1”
全部
107
临床试验
55
药物
29
机构
4
资讯
19
2个月前
Gravity Activates Mitochondrial Translation: Space Station Study Reveals Molecular Pathway Linking Mechanical Forces to Cellular Energy Production
去年
Enhancing Glycolysis via PGK1 Shows Promise in Parkinson's Disease Treatment
去年
Vcare Partners with Huadong Medicine for VC005 JAK1 Inhibitor Commercialization in China
22天前
Study reveals how SGLT2 inhibitors improve failing heart function by activating PANK1
去年
Sareum Holdings Raises £2.4 Million to Advance TYK2/JAK1 Inhibitor SDC-1801
9个月前
China Medical System's JAK1 Inhibitor Povorcitinib Receives Breakthrough Therapy Designation for Vitiligo Treatment
去年
Accropeutics' Oral TYK2/JAK1 Inhibitor Shows Strong Efficacy in Phase 2 Psoriasis Trial
去年
Hengrui Pharmaceutical Secures NMPA Approval for JAK1 Inhibitor Ivarmacitinib in Severe Alopecia Areata
去年
JAK1 Inhibitors Show Superior Antipruritic Effects Over IL-13 Antibodies in Atopic Dermatitis
2个月前
Sareum Completes Dosing in Phase 2-Enabling Toxicology Programme for TYK2/JAK1 Inhibitor SDC-1801
第 1 页,共 2 页
上一页
下一页